The Novel Cardiovascular Therapeutics Summit 2017 is dedicated to challenges in preclinical and clinical cardiovascular research to achieve safer, faster and more cost-effective cardiovascular drug development.
Academics, researchers and senior attendees from the biopharmaceutical industry.
